the neuroguard iep 3-in-1 carotid stent and post-dilation ... · 10 20 30 40 50 60 70 80 90 100 100...
TRANSCRIPT
The Neuroguard IEP®️ 3-in-1 Carotid Stent and Post-Dilation Balloon System with
Integrated Embolic Protection
Ravish Sachar, M.D. F.A.C.C.Physician-in-Chief
Heart and Vascular Service LineUNC-REX Healthcare
University of North Carolina
Disclosure
Speaker name:
.................................................................................
I have the following potential conflicts of interest to report:
Consulting
Employment in industry
Stockholder of a healthcare company
Owner of a healthcare company
Other(s)
I do not have any potential conflict of interest
X
X
Higher Minor Stroke During CAS vs CEAImportance of Micro-Embolization
0,00
1,00
2,00
3,00
4,00
5,00
6,00
7,00
ACT 1 SAPPHIRE CREST EVA 3S
CAS (%)
CEA (%)
• Mas, J.L., et al, Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 Oct 19;355:1660–1671• Brott TG et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010; 363: 11–23• Massop D et al. SAPPHIRE Worldwide Registry first 2,001 patients. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):129-36. doi: 10.1002/ccd.21844.• Kenneth Rosenfield, M.D., M.H.C.D.S., et al, N Engl J Med 2016; 374:1011-1020, March 2016 DOI: 10.1056/NEJMoa1515706
The first device that combines an embolic protection filter and balloon/stent
Platform designed for ease of use, enhanced safety and efficiency
Only filter that allows physicians to adjust filter size and optimize wall apposition
Patented filter design maximizes embolic capture and side branch protection
Reduces hospital inventory costs
Integrated Filter with optimized pore size and design
Angioplasty Balloon
Catheter
Integrated Embolic Protection (IEP)TM
Journal of the Neurological Sciences
Volume 328, Issue 1-2, 15 May
2013, Pages 58-63
Diffusion-weighted lesions
after carotid artery stenting
are associated with cognitive
impairment
Maggio, P.a, Altamura, C.a, Landi,
D.a, Migliore, S.a, Lupoi, D.b, Moffa,
F.c, Quintiliani, L.a, Vollaro, S.a,
Palazzo, P.a, Altavilla, R.a,
Pasqualetti, P.de, Errante,
CONCLUSIONS:
Our study showed that peri-procedural brain microembolic load
impacts negatively on cognitive functions, independently from
the influence of patients-related variables. © 2013 Elsevier B.V.
Cognitive Impairment Due to EmbolizationImportance of Micro-Embolization
J Vasc Surg. 2016 Dec 23. pii:
S0741-5214(16)31513-0. doi:
10.1016/j.jvs.2016.09.057.
Volume of subclinical embolic
infarct correlates to long-term
cognitive changes after
carotid revascularization.
Zhou W, Baughman BD, Soman S,
Wintermark M, Lazzeroni LC,
Hitchner E, Bhat J, Rosen A
.
CONCLUSIONS:
Cognitive assessment of procedure-related subclinical
microemboli is challenging. Volumes of embolic infarct correlate
with long-term cognitive changes, suggesting that
microembolization should be considered a surrogate measure
for carotid disease management.
Published by Elsevier Inc.
The Paladin System has the Highest Capture Efficiency of 4 Embolic Filters Tested
0
10
20
30
40
50
60
70
80
90
100
100
43,75 6,25 0
% o
f 7
5-9
0 µ
mEm
bo
li C
aptu
red
Paladin Competitor 1 Competitor 2 Competitor 3
Data on file at Contego Medical
Paladin filter captured 100% of 75-90 µmembolic particles
Proven Superior Capture Efficiency
0 50 100 150 200 250 300 350
31-40
61-70
91-100
130
160
190
Particle Frequency
Size
, μm
Filter Histological Analysis: Particle Size
24 filters collected for analysis of emboli count and size
The majority of particles captured were
less than 100 microns
Filter Comparison
• From 23 paired samples, the Paladin filter collected on average
• 95% more particles by COUNT and
• 120% more particles between 40-10 microns
than the primary filter
24243
40531042
53332
3013724
0
10000
20000
30000
40000
50000
60000
40-100 101-200 201-400
Co
un
t
Particle Average Length Range (microns)
Number of Embolic Particles Collected in Paladin vs. Primary
Filter
Distal
Proximal
p<0.0001 using the t-test
Slow Flow after Mesh-Covered Stenting
The Paladin filter and Roadsaver captured 68% more particles by
COUNT and 69% more particles
between 40-10 microns
than the primary filter the Roadsaver stent
Comparison of Particle Counts in CAS with Mesh-Covered Stents vs Non-Mesh Covered Stents
1784
117 16
3014
149 520
500
1000
1500
2000
2500
3000
3500
40-100 101-200 201-400
Nu
mb
er o
f p
arti
cles
co
llect
ed
Particle size, microns
Paladin Filter + Roadsaver Stent
N=13
N=10
p=0.13 using the t-test
Stent Thrombosis with Mesh-Covered Stents?
Asymptomatic delayed
stent occlusion after dual
layer micromesh stent
treatment for high grade
carotid artery stenosis
Struffert T., Engelhorn T.,
Gölitz P., Lücking H., Dörfler
A., University of Nuremberg,
Erlangen, GERMANY
Filter Histology in Patient Treated with Mo.MAand Paladin
>30029919940-99
Particle Count 7251362599
725136
2599
Par
ticl
e C
ou
nt
2,599
136299 7
Procedure performed in Leipzig, Germany with Medtronic Mo.MA proximal protection system
Courtesy: Dr. Andrej Schmidt
Particle Size
How can we further improve the carotid stenting procedure?
• Stent deployment in most current procedures is still protected by a distal filter
• Distal filters may not be well opposed to the vessel wall
• Distal filters have > 100 micron pores
• The number of steps in CAS is >9
• Number of steps increases risk of procedure
Neuroguard IEP 3-in-1 System
Neuroguard IEP Carotid Stent
Stent Lengths (30, 40 mm)Mid Stent OD (6, 7 mm)
Neuroguard IEP Carotid StentStent Design
• Asymmetrical tapered design• Flared ends
8 mm7 mm
Neuroguard IEP Carotid Stent
Closed Cell Design
No kinking to >270o
Characteristic ResultStent deployment
accuracy<1 mm
Maximum stent foreshortening
14%
Kink Resistance 278 degrees
Conformability 278 degrees
0
0,1
0,2
0,3
0,4
0,5
0,6
ContegoNeuroguard
7 mm
Abbott Xact7 mm
ContegoNeuroguard
6 mm
Boston SciWallstent 6
mm
N/m
m
Radial Force
Neuroguard IEP Carotid Stent
Abbott Xact® Stent Neuroguard IEP
Optimized Flexibility/Conformability
Neuroguard IEP Carotid Stent
PERFORMANCE I
• Protection against Emboli during carotid stenting using a 3-in-1 delivery system compRising oF a pOst-dilation balloon, integRated eMbolic filter And Novel Carotid stEnt I
– A European feasibility trial of the Neuroguard IEP Carotid Stent System beginning in Q1 2018
– Approximately 100 subjects, with preliminary analysis performed at 56
– The primary endpoint is the 30-day rate of MAE, defined as the cumulative incidence of any periprocedural (≤ 30 days post-procedure) death, stroke or MI.
Investigators Country
Prof. Alberto Cremonesi , Coordinating PI Cotignola, Italy
Prof. Sasko Kedev Skopje, Macedonia
Prof. Ivo Petrov Sofia, Bulgaria
Prof. Dierk Scheinert Leipzig, Germany
Dr. Ralf Langhoff Berlin, Germany
Dr. Zoran Milosevic Ljubljana, Slovenia
PERFORMANCE II
• A US multicenter clinical study to evaluate the safety and efficacy of the Neuroguard IEP Carotid Stent System
• Approximately 300 subjects will be enrolled, and will be followed through 36 months post-procedure
• The primary endpoint is the 30-day rate of major adverse event (MAE), defined as death, stroke or myocardial infarction (MI) within 30 days of the index carotid stenting procedure, and ipsilateral stroke at 12 months of procedure.
• Start Date Q3 2018
• PI: Dr. William Gray
Neuroguard IEP Carotid Stent
Summary
• The biggest risk of stroke is due to inadequate embolic protection during
index procedure, especially during post-dilation
• Micro embolization < 100 micron particles is important and causes minor
stroke
• Trans-femoral or trans-radial stenting with experienced operators using
the Neuroguard IEP system may be a good option and will be
investigated further via the PERFORMACE Series of Trials
Thank you!
The Neuroguard IEP®️ 3-in-1 Carotid Stent and Post-Dilation Balloon System with
Integrated Embolic Protection
Ravish Sachar, M.D. F.A.C.C.Physician-in-Chief
Heart and Vascular Service LineUNC-REX Healthcare
University of North Carolina